GeneOne Life Science signs $2.3M plasmid DNA supply contract

GeneOne Life Science announced a $2.3 million contract to supply plasmid DNA pharmaceuticals to an undisclosed U.S. gene therapy company.

“Every year, around 200 early-stage cell and gene therapy clinical trial applications (IND) are submitted to the U.S. FDA.”asiae.co.kr

• 1 source
• asiae.co.krJinwon Life Sciences Signs $2.3 Million Plasmid DNA Drug Supply Contract - The Asia Business DailyJang HyowonDec 18, 2020

Summarized from public sources; check the original articles before acting on it.